Patient Centric Medication Therapy Management
Optimize outcomes by focusing on medication safety, effectiveness, lower-cost alternatives and adherence.
The public and private sectors now have a better understanding of the negative effects of incorrect medication use, which has led to an increased interest in high-quality Medication Therapy Management (MTM) programs. To improve the effectiveness of covered MTM services and maximize the benefits for Medicare patients, there is a need to restructure the provision for MTM services and standardize the level and quality of services offered.
Although all patients taking medication can benefit from MTM services, Saince recommends that all Medicare beneficiaries should be eligible for an annual comprehensive medication therapy review provided by pharmacist providers.
Our MTM services offer value by promoting the safe, appropriate, and effective use of medications, which can improve patient care and outcomes, such as symptom improvement and adherence, and even save lives. Additionally, our services can significantly reduce healthcare costs, including expenses associated with physician visits, urgent/emergency care visits, and hospitalizations. MTM services can also minimize medication-related adverse events, leading to improved patient safety.
While MA-PD plans can immediately benefit from our MTM services through reduced healthcare costs, such as medical visits and hospitalizations, stand-alone PDPs may not have sufficient incentive to offer comprehensive MTM programs that provide the most beneficial outcomes for patients. Our pharmacist-provided MTM programs, however, can promote adherence and compliance with established medication regimens and treatment guidelines, potentially increasing medication consumption and costs while decreasing overall healthcare expenditures.
Don't miss out on the many benefits of our high-quality Medication Therapy Management services. Contact us today to learn how we can help you improve patient care and outcomes, reduce healthcare costs, and enhance patient safety.
This measure's weight is 1 (medium importance)
To comply, members need to voluntarily enroll with an opt out option, 60 days of participation excludes the members from measure.
